MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

FEBRUARY 14th, 2018

Euronext – Biom’up Announces a Financing Targeting a Total of €43m

Capital increase of an initial amount of €18m which may be increased to €20.7m by means of a public offering without preferential subscription rights and with a priority subscription period of three trading days as of right only

Proposed bond issue with stock warrants of an initial amount of €25m which may be increased to €35m for the benefit of investment funds managed by Athyrium Capital Management, a major US investor in the healthcare sector, which also agrees to take part in the capital increase

The proposed bond issue, which is subject to the Capital Increase achieving at least €15m of its initial amount, will enable the company to refinance the Kreos Capital loan of €8.2m (…)

Read more: https://www.euronext.com/fr/node/739678

ALL NEWS

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.